Filorga acquired by Colgate-Palmolive
Context
The transaction between Filorga and Colgate-Palmolive is a major strategic operation, which enables Colgate-Palmolive to strengthen its position in the personal care market. This acquisition allows Colgate-Palmolive to complete its range of personal care products, by integrating the expertise and products of Filorga. The transaction is also an opportunity for Colgate-Palmolive to strengthen its presence in the European market, where Filorga is already well established. The sale of Filorga to Colgate-Palmolive is the result of a sale process led by Goldman Sachs and BNP Paribas, which has attracted the attention of several cosmetics giants. The transaction is expected to be finalized by the end of the third quarter of 2019.
Filorga, which reported an EBITDA margin of [members only] in 2019, is valued in this transaction at an EV/EBITDA multiple of Above 20x.
-> Deep-dive in Retail & Consumer market trends
Target
Filorga is a leading provider of anti-aging skincare products, present in over 70 countries. The brand has experienced exponential growth in recent years, with a constant increase of at least 50% in sales. Filorga offers a range of high-quality products, benefiting from a unique positioning that has attracted increasingly demanding consumers. The company was founded in 1978 and has developed expertise in the field of anti-aging skincare. Filorga is particularly known for its hyaluronic acid-based anti-wrinkle creams, highly appreciated by Asian consumers. The brand has also developed a significant presence in China, where it has become one of the market leaders. Filorga is a dynamic brand, always looking for new growth opportunities. The company has developed a diversification strategy for its products and markets, in order to strengthen its position in the international market.
Ent. Value
€1–10bn
Equity Value
[members only]
Multiples
EV / Revenue
2x–6x
EV / EBITDA
Above 20x
EV / EBIT
[members only]
Historical Financials (EUR)
Similar deals in Consumer Products
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 01/2020 | SCANDINAVIAN TOBACCO GROUP | ROYAL AGIO CIGARS | NETHERLANDS | Consumer Products |
| 10/2019 | CAPITAL CROISSANCE | ONATERA | FRANCE | Hygiene & Beauty Brands |
| 03/2019 | MAUS FRERES | THE KOOPLES | FRANCE | Fashion & Apparel |
| 01/2019 | L'OCCITANE GROUP | ELEMIS | UNITED KINGDOM | Hygiene & Beauty Brands |
| 08/2018 | MANAGEMENT & PRIVATE INVESTORS | DESIGUAL | SPAIN | Fashion & Apparel |
| 08/2018 | PEPSICO | SODASTREAM | UNITED STATES | Consumer Products |
| 07/2018 | ARGOS WITYU | JURATOYS | FRANCE | Consumer Products |
| 07/2018 | PAI PARTNERS | ASMODEE GROUP | FRANCE | Consumer Products |
| 03/2018 | TOWERBROOK | JJA | FRANCE | Home & DIY |
| 04/2017 | INVESTINDUSTRIAL | ARTSANA | ITALY | Personal & Household |
REFERENCES
Valuation range: EV €1–10bn
Revenue range: €250–500M
EBITDA range: €50–100M
EV/Revenue range: 2x - 6x
EV/EBITDA range: Above 20x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Filorga by Colgate-Palmolive are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: filorga
FAQ
What transaction does this page cover?
How was the acquisition of Filorga by Colgate-Palmolive valued, and what multiples were paid?
What were Filorga’s revenue and EBITDA at the time of the deal?
What sources support the information on this transaction?
What is mynth?